Metropolitan Life Insurance CO Rx Sight, Inc. Transaction History

Metropolitan Life Insurance CO

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$35.51 - $57.92 $4,971 - $8,108	-140 Reduced 8.54%	1,500 $77,000
Q4 2023 Feb 14, 2024	BUY	$20.91 - $40.9 $2,111 - $4,130	101 Added 6.56%	1,640 $66,000
Q3 2023 Nov 14, 2023	BUY	$27.05 - $33.37 $3,624 - $4,471	134 Added 9.54%	1,539 $42,000
Q2 2022 Aug 11, 2022	BUY	$10.61 - $16.66 $14,907 - $23,407	1,405 New	1,405 $20,000

224

32M

394K

32K

Ticker RXST
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 27,638,900
Market Cap $876M
Description
RxSight, Inc., a medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. T...

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

Stay updated on Metropolitan Life Insurance CO with notifications on news.